| 书目名称 | Colon Cancer Diagnosis and Therapy | | 副标题 | Volume 1 | | 编辑 | Ganji Purnachandra Nagaraju,Dhananjay Shukla,Navee | | 视频video | | | 概述 | Describes the causes and early diagnostic tools for effective use of current and future therapeutic regimens.Focuses on immunotherapeutic, nanomedicine, biomarkers, and dietary factors for the effecti | | 图书封面 |  | | 描述 | Colorectal cancer (CRC) is a major global health challenge as the third leading cause for cancer related mortalities worldwide. Despite advances in therapeutic strategies, the five-year survival rate for CRC patients has remained the same over time due to the fact that patients are often diagnosed in advanced metastatic stages. Drug resistance is another common reason for poor prognosis. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early stage diagnosis..This book is the first of three volumes on recent developments in colorectal diagnosis and therapy. Each volume can be read on its own, or together. Each volume focuses on different novel therapeutic advances, biomarkers, and identifies therapeutic targets for treatment. Written by leading international experts in the field, coveragealso addresses the role of diet habits and lifestyle in reducing gastrointestinal disorders and incidence of CRC. Chapters discuss current and future diagnostic and therapeutic options for colorectal cancer patients, focusing on im | | 出版日期 | Book 2021 | | 关键词 | therapeutic strategies; targeted therapy; immunotherapy; nanotechnology; drug resistance; biomarkers; NMR; | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-030-63369-1 | | isbn_ebook | 978-3-030-63369-1 | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
The information of publication is updating
|
|
发表于 2025-3-21 18:06:45
